Epidemiology Report on EpiCast Report Atrial Fibrillation Market Forecast to 2023

EpiCast <strong>Report</strong>:
Atrial Fibrillation -
<strong>Epidemiology</strong> Forecast
to
2023
www.bigmarketresearch.com

<strong>Report</strong> Description
Summary
Atrial fibrillation (AF) is a disorder of the heart’s electrical system. The condition is
characterized by an irregular heart rhythm that is either too fast or too slow. During AF,
the two upper chambers of the heart (atria) beat out of coordination with the two lower
chambers (ventricles) due to disorganized electrical signals, resulting in poor blood
supply to the lungs and the rest of the body. The symptoms of AF typically include heart
palpitations, irregular and fast heartbeat, chest discomfort, shortness of breath,
dizziness, and weakness. However, individuals with AF may be asymptomatic and not
even know that they have the condition until it is identified through an electrocardiogram
(EKG or ECG) test.
Browse complete report @
http://www.bigmarketresearch.com/epicast-report-atrial-fibrillation-epidemiologyforecast-to-2023-market

<strong>Report</strong> Description
AF is one of the most common cardiovascular diseases among the elderly, worldwide.
Although AF affects people of all ages, the condition is rare in individuals younger than 40
years of age. The risk for AF increases rapidly with age and is more common in men than
women. Globally, the prevalence of AF varies widely, depending on the country and the
study, ranging from 0.1-1.6% in Asia (0.1% in India, 1.6% in Japan), 0.95-3.9% in North
America (0.95% in the US, 3.9% in Canada), 1.28-2.1% in Europe (1.28% in the UK, 2.1% in
Germany), and 4.0% in Australia.
GlobalData epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM
will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in
2013 to 12,316,458 diagnosed prevalent cases in 2023.
Feel free to enquire about this report @
http://www.bigmarketresearch.com/report-enquiry/190797

<strong>Report</strong> Description
GlobalData’s epidemiological forecast for the diagnosed prevalent cases of AF in the
8MM is supported by epidemiologic data from country-specific studies that are nationally
representative of the entire population in these markets. This analysis included the most
recently published nationally-representative studies in the 8MM, which provided the
diagnosed prevalence of AF using uniform diagnostic criteria based on EKG tests, which
facilitated a meaningful comparison of the forecast for the diagnosed prevalent cases of
AF in the 8MM.
Need Discount? Request here @
http://www.bigmarketresearch.com/purchase-enquiry/190797

<strong>Report</strong> Description
Scope
The Atrial Fibrillation (AF) EpiCast <strong>Report</strong> provides an overview of the risk factors,
comorbidities, and the global and historical trends for AF in the eight major markets
(8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10-year
epidemiological forecast for the diagnosed prevalent cases of AF segmented by sex, age
(in five-year age groups, beginning at 40 years and ending at =85 years), and clinical
subtypes (paroxysmal, persistent, and permanent AF) in these markets.
The AF epidemiology report is written and developed by Masters- and PhD-level
epidemiologists.
The EpiCast <strong>Report</strong> is in-depth, high quality, transparent and market-driven, providing
expert analysis of disease trends in the 8MM.

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related <strong>Report</strong>s
2.3 Upcoming Related <strong>Report</strong>s
3 <strong>Epidemiology</strong>
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global Trends
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Forecast Assumptions and Methods
3.4.3 Sources Not Used

Table of Contents
3.5 Epidemiological Forecast for Atrial Fibrillation (2013-2023)
3.5.1 Diagnosed Prevalent Cases of Atrial Fibrillation
3.5.2 Age-Specific Diagnosed Prevalent Cases of Atrial Fibrillation
3.5.3 Sex-Specific Diagnosed Prevalent Cases of Atrial Fibrillation
3.5.4 Age-Standardized Diagnosed Prevalence of Atrial Fibrillation
3.5.5 Diagnosed Prevalent Cases of Atrial Fibrillation by Clinical Subtypes
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologists
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and <strong>Epidemiology</strong>

<strong>Report</strong> Description
Reasons to buy
• Develop business strategies by understanding the trends shaping and driving the
global AF market.
• Quantify patient populations in the global AF market to improve product design,
pricing, and launch plans.
• Organize sales and marketing efforts by identifying the sex and age groups that
present the best opportunities for AF therapeutics in each of the markets covered.

FOR MORE DETAILS
Visit us at :
http://www.bigmarketresearch.com/epicast-report-atrialfibrillation-epidemiology-forecast-to-2023-market
Stay With Us:
TELEPHONE: +1 (855) 711-1555
E-MAIL: help@bigmarketresearch.com
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States